Ftse Mib
33.082,62
-0,26%
DAX
19.261,75
-0,22%
S&P 500
5.994,49
-0,45%
NASDAQ
18.991,21
-0,96%
Bitcoin
96.463,67
4,88%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Passage Bio Inc (PASG) Passage Bio Inc (PASG) Notizie

Passage Bio Inc

PASG
0,67
-0,081 (-10,79%)
Ultimo aggiornamento: 18:46:15
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202423:21EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
14/11/202418:03EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
13/11/202413:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202413:00EDGAR2Form 8-K - Current report
13/11/202413:00GLOBEPassage Bio Reports Third Quarter 2024 Financial Results and..
06/11/202413:00GLOBEPassage Bio to Present at Guggenheim Securities Healthcare..
24/10/202413:00EDGAR2Form 8-K - Current report
24/10/202413:00GLOBEPassage Bio Presents Preclinical and Interim Clinical Data..
02/10/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202413:00GLOBEPassage Bio to Present at Chardan’s 8th Annual Genetic..
16/9/202413:00EDGAR2Form 8-K - Current report
16/9/202413:00GLOBEPassage Bio to Present Positive Interim Data from Cohort 1..
10/9/202413:52GLOBEPassage Bio Welcomes Tom Kassberg to Board of Directors
10/9/202413:00EDGAR2Form 8-K - Current report
06/9/202422:15EDGAR2Form 8-K - Current report
30/8/202413:00GLOBEPassage Bio to Present at H.C. Wainwright 26th Annual Global..
09/8/202423:15EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/8/202413:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:00EDGAR2Form 8-K - Current report
08/8/202413:00GLOBEPassage Bio Reports Second Quarter 2024 Financial Results..
06/8/202413:00GLOBEPassage Bio to Participate in Upcoming Investor Conferences
02/8/202422:06EDGAR2Form 8-K - Current report
01/8/202413:00EDGAR2Form 8-K - Current report
01/8/202413:00GLOBEPassage Bio Out-licenses Three Pediatric Gene Therapy..
16/7/202413:01EDGAR2Form 8-K - Current report
16/7/202413:00GLOBEPassage Bio Announces Positive Feedback from FDA on..
05/6/202413:30GLOBEPassage Bio to Present at Goldman Sachs 45th Annual Global..
23/5/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:03EDGAR2Form 8-K - Current report
21/5/202414:00GLOBEPassage Bio Announces Recipient of Third Annual Tachi Yamada..
14/5/202414:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/5/202413:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202413:01EDGAR2Form 8-K - Current report
14/5/202413:00GLOBEPassage Bio Reports First Quarter 2024 Financial Results and..
22/4/202413:00GLOBEPassage Bio to Present at Chardan’s 8th Annual Genetic..
05/3/202413:00GLOBEPassage Bio Seeks Pennsylvania College Student Candidates..
04/3/202423:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/3/202422:09EDGAR2Form S-3 - Registration statement under Securities Act of..
04/3/202413:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04/3/202413:02EDGAR2Form 8-K - Current report
04/3/202413:00GLOBEPassage Bio Reports Fourth Quarter and Full-Year 2023..
29/2/202422:06EDGAR2Form 8-K - Current report
27/2/202413:00GLOBEPassage Bio to Participate in Upcoming Investor Conferences
14/2/202415:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:05EDGAR2Form 8-K - Current report
03/1/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,788 Min: 0,660901 Max: 0,7899
Chiusura: 0,751

La tua Cronologia

NASDAQ
PASG
Passage Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network